Protalix Biotherapeutics to Present at the WORLD Lysosomal Disease Network Symposium 2009

CARMIEL, Israel--(BUSINESS WIRE)--Protalix BioTherapeutics, Inc. (AMEX: PLX), today announced that Dr. Einat Brill Almon, the Company’s Senior Vice President of Product Development, will be presenting at the WORLD Symposium 2009, co-organized by Lysosomal Disease Network and the National Institutes of Health. The symposium will take place February 18 through 20, 2009 at the Westin Gaslamp Quarter in San Diego, California. Dr. Almon’s presentation, entitled “Novel Enzyme Replacement Therapy for Gaucher Disease: On-Going Phase III Clinical Trial with Recombinant Human Glucocerebrosidase Expressed in Plant Cells,” will be delivered on Friday, February 20, 2009 at 9:10 AM PT.